Cancer preventive potential of methanol extracts of hypsizigus marmoreus

Journal of Medicinal Food

Volumn 12, Issue 3, 2009, Pages 493-500

  Chang, Jong Sun ^a   Bae, Joon Tae ^b   Oh, Eun Jung ^c   Kim, Ji Young ^d   Park, Sun Hee ^b   Lee, Kap Rang ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Yeungnam University   (South Korea)

^c Kyungpook National University   (South Korea)

^d Korea Institute of Toxicology   (South Korea)

Author keywords

Antimutagenesis; Cancer chemoprevention; Hypsizigus marmoreus; Phase I enzyme; Phase II enzyme

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BENZO[A]PYRENE; CYTOCHROME P450 1A1; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYPSIZIGUS MARMOREUS EXTRACT; METHANOL; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER PREVENTION; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INDUCTION; HUMAN; HUMAN CELL; HYPSIZIGUS MARMOREUS; LIVER CELL CARCINOMA; MALE; MOUSE; MUSHROOM; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

AGARICALES; ANIMALS; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; BENZO(A)PYRENE; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES A1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MUTAGENICITY TESTS; MUTAGENS; OXAZINES; PLANT EXTRACTS; SALMONELLA TYPHIMURIUM;

BASIDIOMYCOTA; MUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 68149141859     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.1050     Document Type: Article

References (44)

1. Greenberg MR: Cancer Factors and Figures. American Cancer Society, Atlanta, 1995, pp. 1-3.
2. Rogers AE, Zeisel SH, Groopman J: Diet and carcinogensis. Carcinogenesis 1993;14:2205-2217.
3. Guengerich FP: Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 1995;61:651-658.
4. Rice-Evans CA, Miller NJ, Paganga G: Antioxidant properties of phenolic compounds. Trends Plant Sci 1997;2:22-29.
5. Shankel DM, Pillai SP, Telikepalli H, Menon SR, Pillai CA: Role of antimutagens/anticarcinogens in cancer prevention. Biofac- tors 2000;12:113-121.
6. Kusamran WR, Tepsuwan A, Kupradinum P: Antimutagenic and anticarcinogenic potentials of some Thai vegetables. Mutat Res 1998;402:247-258.
7. Ko TF, Weng YM, Lin SB, Chiou RY: Antimutagenicity of supercritical CO2 extracts of Terminalia catappa leaves and cytotoxicity of the extracts to human hepatoma cells. J Agric Food Chem 2003;51:3564-3567.
8. Matsuzawa T, Saitoh H, Sano M, Tomita I, Ohkawa M, Ikekawa T: Studies on antioxidant effects of Hypsizigus marmoreus. II. Effects of Hypsizigus marmoreus for antioxidant activities of tumor-bearing mice. Yakugaku Zasshi 1998;118:476-482.
9. Ikekawa T, Saitoh H, Feng WJ, Zhang HL, Li LF, Matsuzawa T: Antitumor activity of Hypsizigus marmoreus. I. Antitumor activity of extracts and polysaccharides. Chem Pharm Bull 1992; 40:1954-1957.
10. Saitoh H, Feng WJ, Matsuzawa T, Ikekawa T: Antitumor activity of Hypsizigus marmoreus. Preventive effect against lung metastasis of Lewis lung carcinoma. Yakugaku Zasshi 1997;117:1006-1010.
11. Tsuchida K, Aoyagi Y, Odani S, Mita T, Isemura M: Isolation of a novel collagen binding protein from the mushroom, Hypsizigus marmoreus, which inhibits the Lewis lung carcinoma cell adhesion to type IV collagen. J Biol Chem 1995;270:1481-1484.
12. Shoji Y, Isemura MI, Muto H, Isemura S, Aoyagi Y: Isolation of a 41-kDa protein with cell adhesion activity for animal tumor cells from the mushroom, Hypsizigus marmoreus by affinity chromatography with Type IV collagen immobilized on agarose. Biosci Biotechnol Biochem 2000;64:775-780.
13. Chang JS, Son JK, Li G, Oh EJ, Kim JY, Park SH, Bae JT, Kim HJ, Lee IS, Kim OM, Kozukue N, Han JS, Hirose M, Lee KR: Inhibition of cell cycle progression on HepG2 cells by hypsizi- prenol A9, isolated from Hypsizigus marmoreus. Cancer Lett 2004;212:7-14.
14. Cory AH, Owen TC, Barltrop JA, Cory JG: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991;3:207-212.
15. Ames BN, Maron DM: Revised methods for the Salmonella mutagenicity test. Mutat Res 1983;113:173-179.
16. Cai YN, Bennett D, Nair RV, Ceska O, Ashwood Smith M, DiGiovanni J: Inhibition and inactivation of murine hepatic ethoxy-and pentoxyresorufin activities by naturally occurring coumarins. Chem Res Toxicol 1993;6:872-879.
17. Omura T, Sato R: The carbon monooxide binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J Biol Chem 1964;239:237-245.
18. Moron MA, Depierre JW, Mannervick B: Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
19. Habig W, Pabst M, Jakoby W: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
20. Benson A, Hunkeler MJ, Talalay P: Increase of NAD(P)H: quinone reductase by dietary antioxidants. Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 1980;77:5216-5220.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1979;72:248-254.
22. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF: Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. JAppl Toxicol 2003;23:255-261.
23. Cancino-Badias L, Reyes RE, Nosti R, Perez I, Dorado V, Ca- ballero S, Soria A, Camacho-Carranza R, Escobar D, Espinosa- Aguirre JJ: Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods. Mutagenesis 2003;18:95-100.
24. Khan SC, Katiyar SK, Agarwal R, Mukhtar H: Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res 1992;52:4050-4052.
25. Wattenberg LW: Chemoprevention of cancer. Cancer Res 1985; 45:1-8.
26. Mohacek-Grosev V, Bozac R, Puppels GJ: Vibrational spectroscopic characterization of wild growing mushrooms and toadstools. Spectrochim Acta A Mol Biomol Spectrosc 2001;57:2815-2829.
27. Zaidi NH, Potten CS, Margison GP, Cooper DP, O'Connor PJ: Tissue and cell specific methylation, repair and synthesis of DNA in the upper gastrointestinal tract of Wistar rats treated with N-methyl-N'-nitro-N-nitrosoguanidine via the drinking water. Carcinogenesis 1983;14:1991-2001.
28. Xu ML, Choi JY, Jeong BS, Li G, Lee KR, Lee CS, Woo MH, Lee ES, Jahng Y, Chang HW, Lee SH, Son JK: Cytotoxic constituents isolated from the fruit bodies of Hypsizigus marmoreus.Arch Pharm Res 2007;30:28-33.
29. Weisburger JH: Antimutagenesis and anticarcinogenesis, from the past to the future. Mutat Res 2001;480:23-35.
30. Fortson WC, Tedesco FJ, Starnes EC, Shaw CT: Marked elevation of serum transaminase activity associated with extrahepatic biliary tract disease. J Clin Gastroenterol 1985;76:502-505.
31. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH: Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferase. Scand J Gastroenterol 1986;21:109-113.
32. Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM: Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mutat Res 2001;495:135-145.
33. Siess MH, Le Bon AM, Canivenc-Lavier MC, Suschetet M: Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides. Cancer Lett 1997;120:195-201.
34. Guyonnet D, Siess MH, Le Bon AM, Suschetet M: Modulation of phase II enzymes by organosulfur compounds from Allium vegetables in rat tissues. ToxicolApplPharmacol1997;154:50-58.
35. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper FF: Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo(a)pyrene. JAppl Toxicol 2003;23:255-261.
36. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y: Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 1995;82:173-179.
37. Wilkinson J, Clapper WL: Detoxication enzymes and chemo-prevention. Proc Soc Exp Biol Med 1997;216:192-200.
38. Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 1992;89: 2399-2403.
39. Kensler TW, Groopman JD, Sutter TR, Curphey TJ, Roebuck BD: Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem Res Toxicol 1999;12:113-117.
40. Barcelo S, Gardiner JM, Gescher A, Chipman JK: CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 1996;17:277-282.
41. Prochaska HJ, Santamaria AB, Talalay P: Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci USA 1992;89:2394-2398.
42. Egner PA, Kensler TW, Prestera T, Talalay P, Libby AH, Joyner HH, Curphey TJ: Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 1994;15:177-181.
43. Steele VE, Kelloff GJ, Balentine D, Boone CW, Mehta R,Bagheri D, Sigman CC, Zhu S, Sharma S: Comparative che- mopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcino- genesis 2000;21:63-67.
44. Begleiter A, Leith MK, Curphey TJ, Doherty GP: Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Oncol Res 1997;9:371-382.